Vaccine Blocks Some Cancer Recurrence

SPACE MEDICINE

illustration only

Melbourne, Australia (UPI) Jul 20, 2004
Australian researchers have developed a therapeutic cancer vaccine that has appeared to delay cancer recurrence.

Researchers at the Ludwig Institute for Cancer Research and the Australian biotechnology company CSL Limited said the vaccine, called NY-ESO-1/ISCOMATRIXTM, induced a comprehensive immune response in patients and

Of every 19 patients, most with melanoma, treated with three monthly doses of the vaccine following surgical removal of the tumor, 14 remained cancer free over the two years their progress was followed.

The vaccine, which combines a cancer-specific protein with an immune stimulant, appeared to delay the recurrence of cancer, suggesting that some form of protection is being conferred by the vaccine, the researchers said.

Despite the encouraging clinical results, the researchers cautioned that the study was done retrospectively and therefore should be considered less exact than if it been done in a planned, prospective fashion.

Phase II of the study will begin clinical trials in 2005 at cancer centers in Australia, New Zealand and the United Kingdom.

All rights reserved. Copyright 2004 by United Press International. Sections of the information displayed on this page (dispatches, photographs, logos) are protected by intellectual property rights owned by United Press International. As a consequence, you may not copy, reproduce, modify, transmit, publish, display or in any way commercially exploit any of the content of this section without the prior written consent of by United Press International.

SPACE MEDICINE

Space Tech Captures Toxic Micro-Organisms

Paris (ESA) Jul 16, 2004
Sophisticated technology developed to ensure clean air for astronauts onboard space stations is now used in hospitals to capture and destroy airborne fungi, bacteria, spores and viruses. It can also eliminate microorganisms causing SARS, ebola, smallpox, and tuberculosis as well as anthrax.

Thanks for being here; We need your help. The SpaceDaily news network continues to grow but revenues have never been harder to maintain. With the rise of Ad Blockers, and Facebook - our traditional revenue sources via quality network advertising continues to decline. And unlike so many other news sites, we don't have a paywall - with those annoying usernames and passwords. Our news coverage takes time and effort to publish 365 days a year. If you find our news sites informative and useful then please consider becoming a regular supporter or for now make a one off contribution.
SpaceDaily Contributor $5 Billed Once credit card or paypal		SpaceDaily Monthly Supporter $5 Billed Monthly paypal only

The content herein, unless otherwise known to be public domain, are Copyright 1995-2016 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. Privacy Statement All images and articles appearing on Space Media Network have been edited or digitally altered in some way. Any requests to remove copyright material will be acted upon in a timely and appropriate manner. Any attempt to extort money from Space Media Network will be ignored and reported to Australian Law Enforcement Agencies as a potential case of financial fraud involving the use of a telephonic carriage device or postal service.